Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Visualize Index Level and price together to reveal trend strength and timing. This overview helps traders align momentum with price moves.
28,655 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
In July 2026, a conservative strategy using a $185,000 portfolio that covers essential monthly bills shows how a stea...
Federal prosecutors say a California couple ran a crypto-laundering operation tied to darknet fentanyl shipments, mov...
A 47-year-old with no retirement accounts faces a shrinking cushion as inflation cools and rates stay elevated. This ...
ServiceNow signals a measured, growth-focused future as Knowledge 2026 highlights a shift from AI feature wars to the...
Retirees with large pensions are exploring domicile changes to Florida and other states to wipe out California state ...
The Social Security Administration’s new commissioner argues that wait times are down and more people are being serve...
A Portland, Oregon court filing shows Compass has settled the Murch TCPA lawsuit. The terms are confidential, and a n...
Microsoft is expanding its Frontier unit with a multi-billion-dollar push to convert AI spending into tangible enterp...
Age-verification efforts aimed at safeguarding minors are sparking a broader push toward universal online IDs, with p...
APAC startups are accelerating AI adoption as Aspire tracks a 20% rise in AI tool spending among 37,000 SMEs, with co...
The Clarity Act is moving toward markup with more than 100 amendments, spotlighting a fierce clash over stablecoin re...